Quantitative Systems Pharmacology Page
Choose Certara’s Quantitative Systems Pharmacology (QSP) consulting services to enhance drug development with computational modeling and experimental data.
Quantitative Systems Toxicology & Safety Page
Engage our expert QSTS scientific consultants to identify drug toxicity earlier and decrease time to bring your drugs to market.
Pharmacometrics Services Page
Our experienced pharmacometrics services team helps quantify drug-patient interactions, optimize development & regulatory choices.
Model-based Meta Analysis Page
Leverage Certara’s expertise in model-based meta-analysis to enhance trial design and decision-making.
Clinical Pharmacology Page
Analysis and strategies with the main objective of ensuring a successful drug development program.
Local Therapies for the Global COVID-19 Pandemic Blog Post
Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as a therapeutic option for COVID-19 patients.
Data Validation in Clinical Research: Confusing Rules Explained Blog Post
In this webinar, we explore what you should do when rules fire during data validation in clinical research, including when to fix or explain the results.
Applying decision analysis to drug development for COVID-19 & future pandemics Blog Post
This blog discusses how decision analysis approaches can help drug developers to better decisions under multiple criteria and uncertainty.
Getting started with in-house development: storyboarding Blog Post
Introducing our three-part blog series on getting started with in-house development. In this series, we’re detailing some key aspects of how you can create and deploy your own mobile apps,…
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? Blog Post
This webinar will explain how pricing has evolved for the rare disease drug market and best practices for supporting value-based pricing.
